What's happening
This bill requires insurance policies to cover clinically necessary inpatient substance use disorder treatments, broadening coverage and aligning it with federal mental health parity laws.
Why it matters
Shifts the standard from "medically necessary" to "clinically necessary" treatment. , explicitly including both medical needs and social determinants of health (like housing or support systems). This broadens the criteria for approving inpatient substance use disorder care, potentially making it easier for more people to access and keep coverage for longer stays.
Limits insurer authority to deny or restrict coverage. for inpatient substance use disorder treatment: insurers can only deny coverage if the care is not indicated by an evidence-based, state-designated clinical review tool, and denials must be detailed and justified. This increases transparency and may reduce arbitrary or inconsistent denials.
Aligns state insurance requirements with federal mental health parity laws. , ensuring that substance use disorder benefits cannot be more restrictive than those for other medical or surgical conditions. This could improve equity in access to care and reduce disparities in how mental health and addiction treatments are treated by insurers.
Reduces administrative hurdles for patients and providers. , such as prohibiting preauthorization and limiting utilization review during the first 28 days of inpatient care. This can speed up admission to treatment and reduce delays or interruptions in care, which is especially important in urgent or crisis situations.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
People receiving inpatient substance use disorder treatment
The bill would define clinical necessity to include medical needs and social determinants of health that promote stability after discharge.
Residential substance use disorder treatment providers
The bill would replace required coverage of unlimited medically necessary residential treatment with language allowing clinically necessary treatment at the service provider’s discretion.
Health insurers
The bill would require specific explanations for denials of coverage during the initial 28 days of inpatient treatment and expressly subject concurrent and retrospective reviews to federal mental health and addiction parity requirements.
Headline styles
Expand Inpatient Addiction Coverage
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Referred to insurance
- Referred to rules
Full text
3 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
7352
2021-2022 Regular Sessions
IN SENATE
August 27, 2021
Introduced by Sen. HARCKHAM -- read twice and ordered printed, and when printed to be committed to the Committee on Rules
AN ACT to amend the insurance law, in relation to including clinically necessary treatment for certain inpatient coverage
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Paragraph 30 of subsection (i) of section 3216 of the insurance law, as amended by section 5 of subpart A of part BB of chapter 57 of the laws of 2019, is amended to read as follows:
(30)(A) Every policy that provides hospital, major medical or similar comprehensive coverage shall provide inpatient coverage for the diagnosis and treatment of substance use disorder, including detoxification and rehabilitation services. Such inpatient coverage [shall] may include [unlimited medically] clinically necessary treatment for substance use disorder treatment services provided in residential settings at the discretion of the service provider. Further, such inpatient coverage shall not apply financial requirements or treatment limitations, including utilization review requirements, to inpatient substance use disorder benefits that are more restrictive than the predominant financial requirements and treatment limitations applied to substantially all medical and surgical benefits covered by the policy.
(B) Coverage provided under this paragraph may be limited to facilities in New York state that are licensed, certified or otherwise authorized by the office of [alcoholism and substance abuse] addiction services and supports and, in other states, to those which are accredited by the joint commission as alcoholism, substance abuse, or chemical dependence treatment programs and are similarly licensed, certified or otherwise authorized in the state in which the facility is located.
(C) Coverage provided under this paragraph may be subject to annual deductibles and co-insurance as deemed appropriate by the superintendent
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD13063-02-1
S. 7352 2
and that are consistent with those imposed on other benefits within a given policy.
(D) This subparagraph shall apply to facilities in this state that are licensed, certified or otherwise authorized by the office of [alcoholism and substance abuse] addiction services and supports that are participating in the insurer's provider network. Coverage provided under this paragraph shall not be subject to preauthorization. Coverage provided under this paragraph shall also not be subject to concurrent utilization review during the first twenty-eight days of the inpatient admission provided that the facility notifies the insurer of both the admission and the initial treatment plan within two business days of the admission. The facility shall perform daily clinical review of the patient, including periodic consultation with the insurer at or just prior to the fourteenth day of treatment to ensure that the facility is using the evidence-based and peer reviewed clinical review tool utilized by the insurer which is designated by the office of [alcoholism and substance abuse] addiction services and supports and appropriate to the age of the patient, to ensure that the inpatient treatment is [medically] clinically necessary for the patient. Prior to discharge, the facility shall provide the patient and the insurer with a written discharge plan which shall describe arrangements for additional services needed following discharge from the inpatient facility as determined using the evidencebased and peer-reviewed clinical review tool utilized by the insurer which is designated by the office of [alcoholism and substance abuse] addiction services and supports. Prior to discharge, the facility shall indicate to the insurer whether services included in the discharge plan are secured or determined to be reasonably available. Any utilization review of treatment provided under this subparagraph may include a review of all services provided during such inpatient treatment, including all services provided during the first twenty-eight days of such inpatient treatment. Provided, however, [the] such utilization review shall only be imposed to the extent the insurer's requirements are permitted under the federal Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 and applicable regulations (29 U.S.C. § 1185a; 42 U.S.C. § 300gg-26; 45 C.F.R. Parts 146, 147). The insurer [shall] may only deny coverage for any portion of the initial twenty-eight day inpatient treatment on the basis that such treatment was not [medically] clinically necessary if such inpatient treatment was [contrary to] not indicated by the evidence-based and peer reviewed clinical review tool utilized by the insurer which is designated by the office of [alcoholism and substance abuse] addiction services and supports. Any denial must specifically identify: (i) how such treatment was not indicated by the office of addiction services and supports designated clinical review tool; and (ii) how the policy applied the office of addiction services and supports designated tool to the outpatient substance use disorder care in a manner comparable to and no more stringent than the policy's application of its clinical review tool for outpatient medical and surgical benefits covered by the policy. Any concurrent or retrospective review imposed by the plan, both as written and as applied, must be consistent with the federal Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 and applicable regulations (29 U.S.C. § 1185a; 42 U.S.C. § 300gg- 26; 45 C.F.R. Parts 146, 147). An insured shall not have any financial obligation to the facility for any treatment under this subparagraph other than any copayment, coinsurance, or deductible otherwise required under the policy.
S. 7352 3
(E) An insurer shall make available to any insured, prospective insured, or in-network provider, upon request, the criteria for [medical] clinical necessity determinations under the policy with respect to inpatient substance use disorder benefits.
(F) For purposes of this paragraph:
(i) "financial requirement" means deductible, copayments, coinsurance and out-of-pocket expenses;
(ii) "predominant" means that a financial requirement or treatment limitation is the most common or frequent of such type of limit or requirement;
(iii) "treatment limitation" means limits on the frequency of treatment, number of visits, days of coverage, or other similar limits on the scope or duration of treatment and includes nonquantitative treatment limitations such as: medical management standards limiting or excluding benefits based on [medical] clinical necessity, or based on whether the treatment is experimental or investigational; formulary design for prescription drugs; network tier design; standards for provider admission to participate in a network, including reimbursement rates; methods for determining usual, customary, and reasonable charges; fail-first or step therapy protocols; exclusions based on failure to complete a course of treatment; and restrictions based on geographic location, facility type, provider specialty, and other criteria that limit the scope or duration of benefits for services provided under the policy; [and]
(iv) "substance use disorder" shall have the meaning set forth in the most recent edition of the diagnostic and statistical manual of mental disorders or the most recent edition of another generally recognized independent standard of current medical practice, such as the international classification of diseases[.]; and
(v) "clinical necessity" means both an individual's medical needs and any social determinants of health that will promote such individual's stability following discharge from treatment.
(G) An insurer shall provide coverage under this paragraph, at a minimum, consistent with the federal Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 (29 U.S.C. § 1185a).
§ 2. This act shall take effect immediately.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the insurance law, in relation to including clinically necessary treatment for certain inpatient coverage
Purpose
Includes clinically necessary treatment for certain inpatient coverage
Summary of provisions
Section 1 amends paragraph 30 of subsection (i) of section 3216 of the insurance law changing the terminology of coverage from "medically" necessary treatment to "clinically" necessary treatment when referring to treatment provided by the office of addiction services and supports. "Clinical necessity" is defined as both an individual's medical needs and any social determinants of health that will promote such individ- ual's stability following discharge from treatment. Utilization reviews shall only be imposed to the extent the insurer's requirements are permitted under the federal Paul Wellston and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 and applicable regu- lations. Additionally, specifications for denials are established.
Section 2 states the effective date.
Justification
Individuals suffering from alcohol and/or substance use disorder come from many different social and economic backgrounds. Oftentimes, due to their disorder many individuals are experiencing housing instability directly affecting their recovery. Studies have shown substance misuse is both a cause and a result of homelessness, because of this both issues need to be addressed simultaneously. Stable housing during and after treatment decreases the risk of relapse. Providers need the flexi- bility to determine if an individual may continue to be provided services on site while a housing option is secured. This legislation seeks to provide additional support to those in treatment by meeting clinical needs and assisting in crisis stabilization.
Legislative history
This is a new bill.
Fiscal implications
None to the State.
Effective date
This act shall take effect immediately.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.